Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts
Medtronic
Boehringer Ingelheim
AstraZeneca

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020021

See Plans and Pricing

« Back to Dashboard

NDA 020021 describes SUDAFED 24 HOUR, which is a drug marketed by J And J Consumer Inc and is included in one NDA. It is available from one supplier. Additional details are available on the SUDAFED 24 HOUR profile page.

The generic ingredient in SUDAFED 24 HOUR is pseudoephedrine hydrochloride. There are forty-nine drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the pseudoephedrine hydrochloride profile page.
Summary for 020021
Tradename:SUDAFED 24 HOUR
Applicant:J And J Consumer Inc
Ingredient:pseudoephedrine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020021
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUDAFED 24 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020021 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-240 50580-240-01 1 BLISTER PACK in 1 CARTON (50580-240-01) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
SUDAFED 24 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020021 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-669 50580-669-10 2 BLISTER PACK in 1 CARTON (50580-669-10) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength240MG
Approval Date:Dec 15, 1992TE:RLD:Yes

Expired US Patents for NDA 020021

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc SUDAFED 24 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020021-002 Dec 15, 1992   Start Trial   Start Trial
J And J Consumer Inc SUDAFED 24 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020021-002 Dec 15, 1992   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
AstraZeneca
Merck
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.